5-112838671-A-G
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2_SupportingPS4_ModeratePP1_StrongPS3_Supporting
This summary comes from the ClinGen Evidence Repository: The c.3077A>G variant in APC is a missense variant predicted to cause the substitution of asparagine by serine at amino acid position 1026 (p.Asn1026Ser). This variant has been reported to segregate with FAP in ≥ 7 meioses in 2 families (PP1_strong; PMID 18166348, Barcelona internal data). Increased β-catenin regulated transcription activity and decreased binding to β-catenin by surface plasmon resonance are also demonstrated (PS3_Supporting; PMID18166348). This variant has been reported in 2 families meeting phenotypic criteria, resulting in a total phenotype score of 3.5 points (PS4_Moderate, PMID 18166348, Invitae and Barcelona Internal data). Finally, this variant is absent from gnomAD v2.1.1 (PM2_Supporting). In summary, this variant meets the criteria to be classified as Likely Pathogenic for FAP based on the ACMG/AMP criteria applied, as specified by the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel: PP1_Strong, PS4_Moderate, PS3_Supporting, and PM2_Supporting (VCEP specifications version 1; date of approval: 12/12/2022). LINK:https://erepo.genome.network/evrepo/ui/classification/CA16028071/MONDO:0021056/089
Frequency
Consequence
NM_000038.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
APC | NM_000038.6 | c.3077A>G | p.Asn1026Ser | missense_variant | 16/16 | ENST00000257430.9 | NP_000029.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APC | ENST00000257430.9 | c.3077A>G | p.Asn1026Ser | missense_variant | 16/16 | 5 | NM_000038.6 | ENSP00000257430 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461842Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 727220
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial adenomatous polyposis 1 Pathogenic:2
Likely pathogenic, reviewed by expert panel | curation | ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel | Feb 25, 2023 | The c.3077A>G variant in APC is a missense variant predicted to cause the substitution of asparagine by serine at amino acid position 1026 (p.Asn1026Ser). This variant has been reported to segregate with FAP in more than 7 meioses in 2 families (PP1_strong; PMID 18166348, Barcelona internal data). Increased beta-catenin regulated transcription activity and decreased binding to beta-catenin by surface plasmon resonance are also demonstrated (PS3_Supporting; PMID18166348). This variant has been reported in 2 families meeting phenotypic criteria, resulting in a total phenotype score of 3.5 points (PS4_Moderate, PMID 18166348, Invitae and Barcelona Internal data). Finally, this variant is absent from gnomAD v2.1.1 (PM2_Supporting). In summary, this variant meets the criteria to be classified as Likely Pathogenic for FAP based on the ACMG/AMP criteria applied, as specified by the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel: PP1_Strong, PS4_Moderate, PS3_Supporting, and PM2_Supporting (VCEP specifications version 1; date of approval: 12/12/2022). - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 04, 2023 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects APC function (PMID: 18166348). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt APC protein function. ClinVar contains an entry for this variant (Variation ID: 1393312). This missense change has been observed in individual(s) with attenuated familial adenomatous polyposis (AFAP) (PMID: 18166348). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 1026 of the APC protein (p.Asn1026Ser). - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 13, 2023 | The p.N1026S variant (also known as c.3077A>G), located in coding exon 15 of the APC gene, results from an A to G substitution at nucleotide position 3077. The asparagine at codon 1026 is replaced by serine, an amino acid with highly similar properties. This alteration has been reported in the literature to segregate with disease in a family affected with attenuated familial adenomatous polyposis (AFAP) (Menéndez M et al. Gastroenterology, 2008 Jan;134:56-64). In addition, functional studies indicated that the variant impaired binding to beta-catenin and resulted in increased beta-catenin-regulated transcriptional activity (Menéndez M et al. Gastroenterology, 2008 Jan;134:56-64). This amino acid position is highly conserved in available vertebrate species. In addition, in silico predictors for this gene do not accurately predict pathogenicity. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.